News

January 6, 2017

Cure SMA Assists Hundreds of Families in 2016

Cure SMA Assists Hundreds of Families in 2016

Each year, Cure SMA provides thousands of families with vital support and resources to help them live active, engaged and hopeful lives. 

Our programs provide tangible support for families affected by SMA, easing the difficulties of an SMA diagnosis, and showing each family that...

READ MORE   |  

Topics: Support & Care, Our Impact, Front Page News

January 4, 2017

Cure SMA Funding Results in 16 New Research Publications

An important goal of our research funding strategy is to share scientific findings with the broader scientific community. To help accomplish this goal, scientists who recieve Cure SMA funding often publish their findings in peer-reviewed journals. Published articles allow the experiments and results to be reviewed and vetted by other...

READ MORE   |  

Topics: Our Impact, Research, Front Page News

December 23, 2016

FDA Approves Spinraza for SMA

FDA Approves Spinraza for SMA

On December 23, the FDA announced that it has approved SpinrazaTM (nusinersen) to treat spinal muscular atrophy, making it the first-ever FDA-approved therapy for SMA.

We...

READ MORE   |  

Topics: Our Impact, Clinical Trials, Advocacy, Front Page News

Items 1 - 3 of 77  12345678910Next

© 2014 Cure SMA | Privacy Policy

Powered by Blackbaud
nonprofit software